MedPath

合肥国高药业有限公司

Ownership
-
Established
2021-06-21
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution

Product Name
氨溴特罗口服溶液
Approval Number
国药准字H20253832
Approval Date
Apr 8, 2025
NMPA

Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution

Product Name
氨溴特罗口服溶液
Approval Number
国药准字H20253833
Approval Date
Apr 8, 2025
NMPA

Glucosamine Sulfate Capsules

Product Name
硫酸氨基葡萄糖胶囊
Approval Number
国药准字H20253425
Approval Date
Feb 20, 2025
NMPA

Empagliflozin Tablets

Product Name
恩格列净片
Approval Number
国药准字H20249429
Approval Date
Nov 22, 2024
NMPA

Weishengsu C Pian

Product Name
维生素C片
Approval Number
国药准字H34022871
Approval Date
Sep 21, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.